Germany
Japan
United Kingdom
China
Antibodies
View as table Download
USD 500.00
5 Days
USD 500.00
5 Days
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR (Clone 528)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone cA2 (Infliximab))
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-VAP-1 (Clone TK8-14)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-TRP-1, gp75 (Clone TA99)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD29 (Clone K20)
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD37 (Clone WR17)
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Polysialic acid (Clone 735)
| Applications | FC, IHC, IP |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD19 (Clone FMC63)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD3 epsilon (Clone 12F6)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Modifications | This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD8 (Clone G10-1)
| Applications | FC, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-IL-16 (Clone 14.1)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-TLR2 (Clone TL2.1)
| Applications | Bl, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD53 (Clone 161-2 (53/2))
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone EDU-2 (B486))
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-C5aR (Clone S5/1)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Ferret, Human, Rabbit, Cow |
| Conjugation | Unconjugated |
Recombinant Anti-CCR5 (Clone T21/8)
| Applications | ELISA, FC, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EpCAM (Clone KS1/4)
| Applications | ELISA, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD33 (Clone M195)
| Applications | FC, IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD123 (Clone 7G3)
| Applications | FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Reactivities
- Human
Applications
- FC
Antibody Hosts
- Mouse
Isotypes
- IgG2a, kappa
Clonalities
- Monoclonal
Filter by
Target Symbol
- CD3E (2)
- EGFR (2)
- LAG3 (2)
- AOC3 (1)
- BIRC5 (1)
- C5AR1 (1)
- CCR5 (1)
- CD19 (1)
- CD33 (1)
- CD37 (1)
- CD4 (1)
- CD40LG (1)
- CD53 (1)
- CD8 (1)
- EPCAM (1)
- ERBB2 (1)
- HSPA4 (1)
- IGF2R (1)
- IL16 (1)
- IL3RA (1)
- ITGA2B (1)
- ITGAL (1)
- ITGB1 (1)
- ITGB2 (1)
- MS4A1 (1)
- MYC (1)
- POLYSIALIC ACID (1)
- TLR2 (1)
- TLR5 (1)
- TNF (1)
- TYRP1 (1)
- VEGFA (1)
Conjugates
Modifications
Assay Types
Families
- Druggable Genome (5)
- Transmembrane (4)
- Stem cell - Pluripotency (2)
- ES Cell Differentiation/IPS (1)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
- Transcription Factors (1)
Pathways
- Colorectal cancer (2)
- Pathways in cancer (2)
- Acute myeloid leukemia (1)
- Antigen processing and presentation (1)
- Bladder cancer (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Jak-STAT signaling pathway (1)
- Lysosome (1)
- MAPK signaling pathway (1)
- Pathogenic Escherichia coli infection (1)
- Small cell lung cancer (1)
- TGF-beta signaling pathway (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)
- Wnt signaling pathway (1)